Caring Brands (CABR) Net Income towards Common Stockholders (2024 - 2026)
Caring Brands (CABR) posted quarterly Net Income towards Common Stockholders of -$3.9 million for Q1 2026, down 615.16% year-over-year from $747934.9 in Q1 2025, and down 3.13% quarter-over-quarter from -$3.7 million in Q4 2025.
Caring Brands (CABR) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends
Caring Brands' Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at -$3.9 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 615.16% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at -$9.8 million (changed N/A YoY), while the FY2025 annual figure was -$7.4 million, down 2740.12% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$3.9 million, down from -$3.7 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$428906.0 in Q3 2024, with the low at -$3.9 million in Q1 2026.
- The 3-year median for Net Income towards Common Stockholders is -$1.3 million (2024), against an average of -$1.8 million.
- The sharpest annual moves came in 2025 and 2026: Net Income towards Common Stockholders sank 283.88% in 2025, then slumped 615.16% in 2026.
- Caring Brands' Net Income towards Common Stockholders stood at -$862791.0 in 2024, then tumbled by 333.02% to -$3.7 million in 2025, then dropped by 3.13% to -$3.9 million in 2026.
- Business Quant data shows CABR's Net Income towards Common Stockholders at -$3.9 million in Q1 2026, -$3.7 million in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 710.19 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Caring Brands | 11.78 Mn | 9.96 Mn | - | -935,019.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -935,019.00 |
| Mar 31, 2026 | -3.85 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -538,770.00 |
| Dec 31, 2024 | -862,791.00 |
| Sep 30, 2024 | -428,906.00 |